Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
RESEARCH TOOLSreports
Holding RARE?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 139.49M | $ 147.03M | $ 108.83M | $ 127.39M | $ 98.05M |
| Gross Profit | $ 139.49M | $ 147.03M | $ 108.83M | $ 103.08M | $ 98.05M |
| EBIT | $ -133.21M | $ -130.74M | $ -154.38M | - | $ -159.00M |
| EBITDA | $ -124.46M | $ -118.12M | $ -145.54M | - | $ -151.81M |
| Net Income Common Stockholders | $ -133.52M | $ -131.60M | $ -170.68M | $ -123.19M | $ -159.65M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 621.61M | $ 763.82M | $ 412.08M | $ 577.21M | $ 442.09M |
| Total Assets | $ 1.54B | $ 1.62B | $ 1.31B | $ 1.49B | $ 1.24B |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -621.61M | $ -763.82M | $ -412.08M | $ -577.21M | $ -442.09M |
| Total Liabilities | $ 1.18B | $ 1.19B | $ 1.17B | $ 1.22B | $ 1.21B |
| Stockholders Equity | $ 346.83M | $ 432.42M | $ 140.26M | $ 275.41M | $ 31.71M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -68.61M | $ -81.47M | $ -203.94M | - | $ -121.57M |
| Operating Cash Flow | $ -67.00M | $ -76.96M | $ -190.73M | $ -83.90M | $ -117.87M |
| Investing Cash Flow | $ -275.50M | $ 60.56M | $ 94.44M | $ -107.02M | $ 64.30M |
| Financing Cash Flow | $ 11.17M | $ 384.94M | $ -58.00K | $ 330.61M | $ 25.23M |